Anti-Mullerian Hormone Levels are Lower in BRCA2 Mutation Carriers

OBJECTIVE: To compare Anti-Mullerian Hormone (AMH) levels in women at high risk for hereditary breast and ovarian cancer compared to healthy, low-risk controls. DESIGN: Prospective cohort SETTING: Ambulatory PATIENT(S): Reproductive age women with a uterus and both ovaries were analyzed in four grou...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Fertil Steril
Auteurs principaux: Johnson, Lauren, Sammel, Mary D., Domchek, Susan, Schanne, Allison, Prewitt, Maureen, Gracia, Clarisa
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5531590/
https://ncbi.nlm.nih.gov/pubmed/28476184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.fertnstert.2017.03.018
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires